Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (HCV) infection in patients with severe renal impairment: A multicentre experience - Munoz-Gomez, R.; Rincon, D.; Ahumada, A.; Hernandez, E.; Devesa, M. J.; Izquierdo, S.; Ortiz, M.; Hernandez-Albujar, A.; Fernandez-Rodriguez, C.; Calvo, M.; Gonzalez, R.; Lozano, M.; et al. (Journal Of Viral Hepatitis, 2017)